TCRT icon

Alaunos Therapeutics

154 hedge funds and large institutions have $270M invested in Alaunos Therapeutics in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 40 increasing their positions, 46 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

more ownership

Funds ownership:

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

13% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 46

20% less capital invested

Capital invested by funds: $336M → $270M (-$66.8M)

Holders
154
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.98M
Puts
$2.32M
Net Calls
Net Calls Change

Top Buyers

1 +$3.47M
2 +$1.93M
3 +$1.91M
4
Two Sigma Investments
Two Sigma Investments
New York
+$1.89M
5
Bank of America
Bank of America
North Carolina
+$1.52M

Top Sellers

1 -$899K
2 -$590K
3 -$507K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$396K
5
UBS Group
UBS Group
Switzerland
-$273K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$862K
27
$822K
28
$810K
29
$738K
30
$728K
31
$715K
32
$704K
33
$671K
34
$659K
35
$576K
36
$529K
37
$523K
38
$516K
39
$508K
40
$492K
41
$487K
42
$469K
43
$466K
44
$458K
45
$408K
46
$396K
47
$377K
48
$322K
49
$321K
50
$314K